| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.11 | 0.5 |